Skip to main content

Table 2 Candidate SNP association analysis

From: Susceptible gene polymorphism in patients with three-vessel coronary artery disease

Gene

SNP

Allele model

MACCE group (n = 342)

Non-CAD group

(n = 344)

P-value

CDKN2B-AS1

rs1063192 A > G

DO AA/GG + GA

223/119

195/149

0.022

RE GG/GA + AA

14/328

15/329

0.862

CO GG/GA/AA

14/105/223

15/134/195

0.066

rs10757274 A > G

DO AA/GG + GA

74/268

112/232

0.001

RE GG/GA + AA

94/248

65/279

0.008

CO GG/GA/AA

94/174/74

65/167/112

0.001

rs1333042 G > A

DO GG/AA+GA

177/165

136/208

0.001

RE AA/GA + GG

23/319

35/309

0.104

CO AA/GA/GG

23/142/177

35/173/136

0.004

rs1333049 G > C

DO GG/CC + GC

67/275

105/239

0.001

RE CC/GC + GG

101/241

69/275

0.004

CO CC/GC/GG

101/174/67

69/170/105

0.001

rs3217986 T > G

DO TT/GG + GT

279/63

303/41

0.018

RE GG/GT + TT

3/339

0/344

0.082

CO GG/GT/TT

3/60/279

0/41/303

0.023

rs4977574 A > G

DO AA/GG + GA

73/269

111/233

0.001

RE GG/GA + AA

94/248

65/279

0.008

CO GG/GA/AA

94/175/73

65/168/111

0.001

rs9632884 C > G

DO CC/GG + GC

192/150

152/192

0.002

RE GG/GC + CC

26/316

25/319

0.867

CO GG/GC/CC

26/124/192

25/167/152

0.004

ADAMTS13

rs1055432 C > A

DO CC/AA+AC

242/99

266/78

0.057

RE AA/AC + CC

4/337

3/341

0.695

CO AA/AC/CC

4/95/242

3/75/266

0.164

ABO

rs8176694 T > C

DO TT/CC + CT

315/25

300/40

0.050

RE CC/CT + TT

6/334

11/329

0.219

CO CC/CT/TT

6/19/315

11/29/300

0.141

  1. CO codominant model, DO dominant model, MACCE major adverse cardiovascular and cerebrovascular events, RE recessive model, SNP single nucleotide polymorphism